Coronavirus disease (COVID-19)-associated mucormycosis (CAM): The unholy triad of COVID-19, diabetes mellitus, and corticosteroid therapy
The whole world has battled with multiple waves of coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 virus. However, the second wave of COVID-19 had caused a worldwide havoc in terms of disease transmissibility, severity, and mortality. India has...
Main Authors: | Deepak Juyal, Shekhar Pal, Nidhi Negi, Minakshi Singh, Manish Kumar, Shweta Singhal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2023;volume=12;issue=11;spage=2538;epage=2541;aulast=Juyal |
Similar Items
-
Challenges in the management of severe cutaneous mucormycosis: A case of rapid progression in uncontrolled diabetes mellitus with polymicrobial implications
by: Sara Harrar, et al.
Published: (2024-06-01) -
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
by: Abanoub Riad, et al.
Published: (2021-10-01) -
Epidemiology and management of mucormycosis in India – Pre- and Post-COVID-19
by: Nandini Sethuraman
Published: (2021-01-01) -
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
by: Maria Panagiota Almyroudi, et al.
Published: (2022-12-01) -
A systematic review of mucormycosis cases in COVID-19: Is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids?
by: Rajesh Kumar, et al.
Published: (2022-01-01)